clarithromycin has been researched along with Extensively Drug-Resistant Tuberculosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brouqui, P; Drancourt, M; Quenard, F | 1 |
Achar, J; Bobokhojaev, OI; du Cros, P; Dusmatova, Z; Quinnell, S; Seddon, JA; Swaminathan, A | 1 |
Agnihotri, SP; Gupta, P; Gupta, S; Jain, NK; Sharma, KK | 1 |
1 review(s) available for clarithromycin and Extensively Drug-Resistant Tuberculosis
Article | Year |
---|---|
Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB).
Topics: Antitubercular Agents; Clarithromycin; Clofazimine; Drug Resistance, Multiple, Bacterial; Drug Synergism; Extensively Drug-Resistant Tuberculosis; Humans; Minocycline; Mycobacterium tuberculosis; Phenothiazines; Sulfonamides | 2017 |
2 other study(ies) available for clarithromycin and Extensively Drug-Resistant Tuberculosis
Article | Year |
---|---|
Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Child; Child, Preschool; Clarithromycin; Clofazimine; Drug Combinations; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Linezolid; Male; Retrospective Studies; Sputum; Tajikistan; Treatment Outcome | 2016 |
Extensively drug resistance (XDR) tb is not always fatal.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Aza Compounds; Capreomycin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; India; Injections; Male; Moxifloxacin; Quinolines; Sputum; Treatment Outcome | 2009 |